CT Will Be Under the Spotlight for Marijuana Legalization in 2021

CT Will Be Under the Spotlight for Marijuana Legalization in 2021

Voters in Arizona, Montana, New Jersey, and South Dakota approved marijuana legalization ballot initiatives last month. To date, over 36 states have legalized medical marijuana, including Connecticut, and 15 states have now legalized marijuana for adults 21 and over – so-called “recreational” marijuana. Connecticut is not one of them, but there’s a chance that may change next year.

Read More

As Restaurants Close During Pandemic, Milford’s Dockside Brewery Among Those Opening

As Restaurants Close During Pandemic, Milford’s Dockside Brewery Among Those Opening

We’ve seen the headlines, and it comes as no surprise. More than 600 restaurants in Connecticut have closed since the pandemic arrived in March, most despite their best efforts to survive. Yet, some have managed to swim against the tide and remain open, including some that have opened for the first time.

Read More

Fiscal Concerns Accompany Good News at Yale School of Public Health

Fiscal Concerns Accompany Good News at Yale School of Public Health

The Yale School of Public Health has been on a roll during the past few months, even as it was encountering a noisy bump in the road. The good news: Dr. Anthony Fauci, will give the 2021 commencement address. Marcella Nunez-Smith will serve in the incoming Biden Administration, leading a new COVID-19 task force on equity issues. But there’s more swirling about.

Read More

Music Beats Cancer – A New Approach Launched in CT Seeks to Advance Cancer Research, Harnessing Support for Innovative Biotech Firms

Music Beats Cancer – A New Approach Launched in CT Seeks to Advance Cancer Research, Harnessing Support for Innovative Biotech Firms

An initiative launched in Connecticut is taking direct aim at opening up the way in which critical research is funded, with the most elusive of illnesses – cancer – clearly in its sights. It is innovative crowd-funding, designed to fill the funding gap that has proven to be a hurdle that many biotech cancer research initiatives – despite how promising they may be - just can’t get beyond.

Read More